Plasmid DNA encoding IFN-δ-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 168, Issue 11, 2002, Pages 5885-5892

  Wildbaum, Gizi ^a   Netzer, Nir ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL POLARITY; FEMALE; GENE THERAPY; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0036604393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.11.5885     Document Type: Article

References (46)

1. Experimental allergic encephalomyelitis: A useful model for multiple sclerosis
2. Multiple sclerosis
3. A new class of membranebound chemokine with a CX3C motif
4. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
5. Chemokines
6. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
7. Chemokines and T lymphocytes: More than an attraction
8. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease experimental autoimmune encephalomyelitis
9. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model
10. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model
11. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
12. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
13. A Toll-like receptor recognizes bacterial DNA
14. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA
15. Augmentation of natural immunity to a proinflammatory cytokine (TNF-α) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis
16. A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis
17. A targeted DNA vaccine augments the natural immune response to self TNF-α and suppresses ongoing adjuvant arthritis
18. Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines
19. Prevention of experimental autoimmune encephalomyelitis by MIP-1α and MCP-1 naked DNA vaccines
20. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis
21. Interferoninducible T cell α chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
22. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
23. + T cells
24. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice
25. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
26. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes
27. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
28. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
29. - T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis
30. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein
31. b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells
32. Short peptide based tolerogens without antigenic activity reverse autoimmunity
33. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoidinducible member of the scavenger receptor cysteine-rich family (CD163)
34. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
35. Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis
36. Neutralizing antibodies to IFN-δ-inducing factor prevent experimental autoimmune encephalomyelitis
37. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
38. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
39. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
40. Systemic immunological effects of cytokine genes injected into skeletal muscle
41. Vaccination against tuberculosis by DNA injection
42. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity
43. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: Modulation of T cell costimulation
44. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway
45. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis
46. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for programmed cell death as a mechanism to control inflammation in the brain